文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

结直肠侧向发育型肿瘤的内镜切除:临床病理特征及治疗结果的危险因素

Endoscopic resection of colorectal laterally spreading tumors: Clinicopathologic characteristics and risk factors for treatment outcomes.

作者信息

Guo Li-Hua, Hu Ke-Feng, Miao Min, Ding Yong, Zhang Xin-Jun, Ye Guo-Liang

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Ningbo University, Ningbo 315020, Zhejiang Province, China.

出版信息

World J Gastrointest Endosc. 2025 Jun 16;17(6):106412. doi: 10.4253/wjge.v17.i6.106412.


DOI:10.4253/wjge.v17.i6.106412
PMID:40547554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12179953/
Abstract

BACKGROUND: Colorectal laterally spreading tumors (LSTs) are best treated with endoscopic submucosal dissection or endoscopic mucosal resection. AIM: To analyze the clinicopathological and endoscopic profiles of colorectal LSTs, determine predictive factors for high-grade dysplasia (HGD)/carcinoma (CA), submucosal invasion, and complications. METHODS: We retrospectively assessed the endoscopic and histological characteristics of 375 colorectal LSTs at our hospital between January 2016 and December 2023. We performed univariate and multivariate analysis to identify risk factors associated with HGD/CA, submucosal invasion and complications. RESULTS: The numbers of granular (LST-G) and non-granular LST (LST-NG) were 260 and 115, respectively. The rates of low-grade dysplasia and HGD/CA were 60.3% and 39.7%, respectively. Multivariate analysis indicated that a tumor size ≥ 30 mm [odds ratio (OR) = 1.934, = 0.032], LST granular nodular mixed type (OR = 2.100, = 0.005), and LST non-granular pseudo depressed type (NG-PD) (OR = 3.016, = 0.015) were independent risk factors significantly associated with higher odds of HGD/CA. NG-PD (OR = 6.506, = 0.001), tumor size (20-29 mm) (OR = 2.631, = 0.036) and tumor size ≥ 30 mm (OR = 3.449, = 0.016) were associated with increased odds of submucosal invasion. Tumor size ≥ 30 mm (OR = 4.888, = 0.003) was a particularly important predictor of complications. A nomogram model demonstrated a satisfactory fit, with an area under the receiver operating characteristic curve of 0.716 (95% confidence interval: 0.653-0.780), indicating strong predictive performance. CONCLUSION: The novel nomogram incorporating tumor size, location, and morphology predicted HGD/CA during endoscopic resection for LSTs. NG-PD lesions larger than 20 mm were more likely to invade the submucosa. Tumor size ≥ 30 mm was an important predictor of complications.

摘要

背景:结直肠侧向发育型肿瘤(LSTs)最好采用内镜黏膜下剥离术或内镜黏膜切除术治疗。 目的:分析结直肠LSTs的临床病理和内镜特征,确定高级别异型增生(HGD)/癌(CA)、黏膜下层浸润及并发症的预测因素。 方法:我们回顾性评估了2016年1月至2023年12月间我院375例结直肠LSTs的内镜及组织学特征。我们进行了单因素和多因素分析,以确定与HGD/CA、黏膜下层浸润及并发症相关的危险因素。 结果:颗粒型(LST-G)和非颗粒型LST(LST-NG)的数量分别为260例和115例。低级别异型增生和HGD/CA的发生率分别为60.3%和39.7%。多因素分析表明,肿瘤大小≥30 mm [比值比(OR)=1.934,P = 0.032]、LST颗粒结节混合型(OR = 2.100,P = 0.005)和LST非颗粒假凹陷型(NG-PD)(OR = 3.016,P = 0.015)是与HGD/CA发生几率显著相关的独立危险因素。NG-PD(OR = 6.506,P = 0.001)、肿瘤大小(20 - 29 mm)(OR = 2.631,P = 0.036)和肿瘤大小≥30 mm(OR = 3.449,P = 0.016)与黏膜下层浸润几率增加相关。肿瘤大小≥30 mm(OR = 4.888,P = 0.003)是并发症的一个特别重要的预测因素。列线图模型显示拟合良好,受试者操作特征曲线下面积为0.716(95%置信区间:0.653 - 0.780),表明预测性能良好。 结论:纳入肿瘤大小、位置和形态的新型列线图可预测LSTs内镜切除术中的HGD/CA。直径大于20 mm的NG-PD病变更易侵犯黏膜下层。肿瘤大小≥30 mm是并发症的重要预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce66/12179953/b38e545008f9/wjge-17-6-106412-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce66/12179953/1f632d807b45/wjge-17-6-106412-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce66/12179953/b38e545008f9/wjge-17-6-106412-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce66/12179953/1f632d807b45/wjge-17-6-106412-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce66/12179953/b38e545008f9/wjge-17-6-106412-g002.jpg

相似文献

[1]
Endoscopic resection of colorectal laterally spreading tumors: Clinicopathologic characteristics and risk factors for treatment outcomes.

World J Gastrointest Endosc. 2025-6-16

[2]
Clinical Pathological Features and Carcinogenic Risk Factors of Colorectal Lateral Spreading Tumors With Skirt Features.

Can J Gastroenterol Hepatol. 2025-6-11

[3]
Predictors for malignant potential and deep submucosal invasion in colorectal laterally spreading tumors.

World J Gastrointest Oncol. 2022-7-15

[4]
Treatment policy for colonic laterally spreading tumors based on each clinicopathologic feature of 4 subtypes: actual status of pseudo-depressed type.

Gastrointest Endosc. 2020-11

[5]
Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.

Cochrane Database Syst Rev. 2022-6-6

[6]
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

Health Technol Assess. 2006-3

[7]
Hypertonic solution as an optimal submucosal injection solution for endoscopic resection of gastrointestinal mucosal lesions: Systematic review and network meta-analysis.

Dig Endosc. 2024-6

[8]
Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease.

Cochrane Database Syst Rev. 2017-11-2

[9]
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Cochrane Database Syst Rev. 2017-12-22

[10]
Clinical outcomes of endoscopic resection for colorectal laterally spreading tumors with advanced histology.

Surg Endosc. 2018-10-22

本文引用的文献

[1]
Endoscopic Submucosal Dissection (ESD) for the Management of Fibrotic Non-Lifting Colorectal Lesions (NLCLs): Results from a Large Multicenter Retrospective Study.

Cancers (Basel). 2025-4-6

[2]
Recurrences of advanced sessile and lateral spreading colorectal adenoma after endoscopic mucosal resection (EMR) thermal ablation versus no adjuvant therapy (RESPECT): a protocol of an international randomized controlled trial.

Trials. 2024-2-17

[3]
Management of complications related to colorectal endoscopic submucosal dissection.

Clin Endosc. 2023-7

[4]
Clinical outcomes of endoscopic submucosal dissection for colorectal neoplasms: A single-center experience in Southern Taiwan.

PLoS One. 2022

[5]
Predictors for malignant potential and deep submucosal invasion in colorectal laterally spreading tumors.

World J Gastrointest Oncol. 2022-7-15

[6]
Utility of a deep learning model and a clinical model for predicting bleeding after endoscopic submucosal dissection in patients with early gastric cancer.

World J Gastroenterol. 2022-6-28

[7]
Endoscopic submucosal dissection for colorectal laterally spreading tumors: Clinical outcomes and predictors of technical difficulty.

J Dig Dis. 2022-4

[8]
Endoscopic characterization of colorectal neoplasia with different published classifications: comparative study involving CONECCT classification.

Endosc Int Open. 2022-1-14

[9]
Location, morphology and invasiveness of lateral spreading tumors in the colorectum differ between two large cohorts from an eastern and western country.

Gastroenterol Hepatol. 2022

[10]
Treatment policy for colonic laterally spreading tumors based on each clinicopathologic feature of 4 subtypes: actual status of pseudo-depressed type.

Gastrointest Endosc. 2020-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索